Cytiva Acquires Aseptic Filling Firm Vanrx Pharmasystems
Source: Vanrx Pharmasystems
February 4, 2021
Cytiva acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges. The deal marks the first acquisition by Cytiva.
“Since becoming a Danaher operating company in April 2020, we have already begun fueling innovation and re-investing in the business for the benefit of our customers and their patients,” says Emmanuel Ligner, president and CEO of Cytiva. “We are thrilled to welcome the Vanrx associates to our family and look forward to working together on delivering meaningful solutions for biomanufacturers.”
The Vanrx portfolio complements Cytiva’s manufacturing capacity solutions, according to Ligner, adding that while great progress has until now focused on drug substances, this innovation is focused on drug product, which he calls a “critical last step” before distribution to patients.
Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling innovator
USA - English
Share this article
- Addition to portfolio supports global trends towards smaller manufacturing and the advent of personalized therapies
- First acquisition by company since becoming Cytiva in April 2020
AMERSHAM, United Kingdom, Feb. 1, 2021 /PRNewswire/ Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges with reduced risk and increased speed to patients.
SA25 Front Operator (PRNewsFoto/Cytiva)
This is the first acquisition by Cytiva. Emmanuel Ligner, President and CEO, Cytiva, says: Since becoming a Danaher operating company in April 2020, we have already begun fueling innovation and re-investing in the business for the benefit of our customers and their patients. We are thrilled to welcome the Vanrx associates to our family and look forward to working together on delivering meaningful soluti